ライフサイエンスコーパス: urological

1 ls per year) and highest following suspected urological (2110) or lung cancer (1835) referral.

2 teral reflux (VUR) is one of the most common urological abnormalities in infants and children.

3 in the anophthalmic group (P = .003), while urological abnormalities were particularly seen in the O

4 ancy-related factors, gynecological factors, urological and gastrointestinal tract factors, comorbid

5 ly neurological, musculoskeletal and facial, urological and genital, or cardiac.

6 The disorder is a dangerous urological and hematological emergency since it is assoc

7 cant risk factor for severe nephropathy, and urological and hepatobiliary cancers (among others) that

8 way, the highest absolute rates were for the urological and lung pathways.

9 accompanied by diabetes insipidus, deafness, urological and neurological complications in combination

10 Recommendations by authoritative urological and oncological societies regarding the use o

11 r spraying was associated with neurological, urological, and skin symptoms (respectively, p < 0.001,

12 ng general, colorectal, hernia, gynecologic, urological, and thoracic indications.

13 nd that drugs from antihypertensives agents, urologicals, and antithrombotic agents (macitentan, bose

14 Vesicoureteric reflux (VUR) is the commonest urological anomaly in children.

15 r symptoms of LUT dysfunction, and follow-up urological assessment may be of benefit for pediatric ca

16 rehensive Cancer Network (NCCN) and American Urological Association (AUA) provide guidelines for surv

17 Patients were identified in the American Urological Association (AUA) Quality (AQUA) Registry, a

18 mplementation of signals during the American Urological Association (AUA) urology match may inform fu

19 tract symptom questionnaire of the American Urological Association (n = 1934); non-cases were men wh

20 he European Association of Urology, American Urological Association and National Institute of Clinica

21 cross-sectional study used the 2019 American Urological Association Annual Census data and the Accred

22 he 2003 and 2004 proceedings of the American Urological Association as well as published literature f

23 The guidelines presented by the American Urological Association give a formal framework for the m

24 we suggest modifications to the new American Urological Association guidelines based on the authors'

25 Francisco Matching Program, and the American Urological Association Matching Program from 1996 to 200

26 ancer Prevention Committee, and the American Urological Association Practice Guidelines Committee joi

27 Subsequently, the American Urological Association recommended beginning screening a

28 Patients were grouped by age per American Urological Association screening guidelines: group 1, pa

29 Twenty-eight tumors of American Urological Association stages B and C were selected for

30 s were changes in the scores on the American Urological Association Symptom Index (AUASI) and the max

31 ry flow rate of at least 4 mL/s, an American Urological Association Symptom Index (AUASI) score of be

32 ymptom severity was assessed by the American Urological Association Symptom Index (AUASI), and peak u

33 t questionnaires they completed the American Urological Association symptom index (AUASI).

34 symptom questions modified from the American Urological Association symptom index in 1992 and 1994 (n

35 te and who scored 0-7 points on the American Urological Association symptom index on all questionnair

36 f moderate/severe urinary symptoms (American Urological Association Symptom Index score >7), low maxi

37 The mean American Urological Association Symptom Index score was well belo

38 Components of BPH, including American Urological Association Symptom Index scores, peak urinar

39 r progression of BPH as measured by American Urological Association Symptom Index scores, peak urinar

40 evere LUTS (> or = 15 points on the American Urological Association symptom index) on any study quest

41 se line of at least 4 points in the American Urological Association symptom score, acute urinary rete

42 American Urological Association symptom scores and peak urinary-f

43 rved clinical examination data, the American Urological Association Symptoms Score showed a surprisin

44 rtion of men treated with RP across American Urological Association tumor risk and PCCI (a validated

45 ear Medicine and Molecular Imaging, American Urological Association, American Society for Radiation O

46 he European Association of Urology, American Urological Association, and the College of American Path

47 Medicine, American Cancer Society, American Urological Association, and U.S. Preventive Services Tas

48 the American College of Radiology, American Urological Association, European Association of Urology,

49 ional Cancer Center Network and the European Urological Association.

50 astroenterological Association, and American Urological Association.

51 of T1 renal masses put forth by the American Urological Association.

52 ian, cervical, and vaginal), 35.7% (n = 462) urological (bladder), 18.1% (n = 234) anal, and 5.7% had

53 a 6%, 7%, and 9%, increased risk of overall urological, bladder, and kidney cancer, respectively; an

54 d to a 3%, 4%, and 4% higher risk of overall urological, bladder, and prostate cancer, respectively.

55 l from the top 30 countries with the highest urological cancer burden.

56 3) could reduce the age-standardized rate of urological cancer by 1.5 ~ 27/100,000 across the 15 coun

57 er, whether air pollution is associated with urological cancer is largely unknown.

58 ll carcinoma (RCC), the third most prevalent urological cancer, claims more than 100,000 lives/year w

59 Immunotherapies have long been used to treat urological cancers but rarely lead to cure.

60 implications between tissue-oriented domains.Urological cancers have disparate tissues and cells of o

61 nsive molecular characterization to classify urological cancers into nine major genomic subtypes, hig

62 Regarding urological cancers, climate change will probably increas

63 d (3) location of most of the postdiagnostic urological care encounters.

64 Despite major advances in the urological care of spinal cord injury patients, the inci

65 ), climate change and urological disease and urological care providers face many challenges in the er

66 Existing urological clinical trials are often limited by small nu

67 recent years, although it is plain that the urological community is still divided regarding their us

68 outcomes and increased popularity within the urological community.

69 semination over the past few years in the US urological community.

70 evere irritative symptoms or the presence of urological comorbidity, such as bladder stones, increase

71 he same organism associated with significant urological comorbidity.

72 led for the potential confounders sex, age, (urological) comorbidity, febrile UTI, and intensive care

73 Ureteric stricture is the most common urological complication following renal transplantation.

74 ractivity during the late stage, is a common urological complication of diabetes.

75 abetic bladder dysfunction (DBD) is a common urological complication of diabetes.

76 ent placement in children in this era of low urological complication rates and BKVAN needs reevaluati

77 There was only one grade 2 urological complication, which occurred in a patient who

78 sed, but associated with a high incidence of urological complications (acidosis, dehydration, pancrea

79 Major urological complications (MUCs) after kidney transplanta

80 The double-J-stent has been used to prevent urological complications (UCs), but it requires cystosco

81 .39-0.80; p = 0.001) for the total number of urological complications 0.56 (CI 0.41-0.76; p < 0.001)

82 Urological complications and polyoma infection were the

83 Neurogenic bladder dysfunction causes urological complications and reduces the quality of life

84 Urological complications are still a major problem posto

85 neocystostomy for having a smaller amount of urological complications in kidney transplantation.

86 ons, including events such as lymphocele and urological complications that affect wound healing, are

87 ncidence of posttransplantation vascular and urological complications, long-term graft survival after

88 Urological complications, namely ureteral leak and obstr

89 nting in renal transplantation reduces major urological complications; however, morbidity is related

90 infrequently seen and challenging pediatric urological condition that in addition to causing obstruc

91 Many urological conditions are common, recurrent or chronic,

92 lthy volunteers, and 13 patients with benign urological conditions).

93 With respect to benign urological conditions, epidemiological studies suggest t

94 ds has favourable associations with multiple urological conditions.

95 anagement, and outcome prediction of various urological conditions.

96 ere recruited between 2007 and 2016 from the Urological Department in N.N. Blokhin National Medical R

97 mized, controlled trial was conducted in two urological departments in Denmark from January 2018 to A

98 llel randomised controlled trial in 5 Danish urological departments.

99 tions in DSTYK were implicated in congenital urological developmental disorders, but our study identi

100 Recent urological developments focus on modification of techniq

101 carbonate and oxalate) and biofilm found in urological devices.

102 -jet flows, and apply this to the problem of urological diagnosis in this first ever study of the bio

103 that support our health), climate change and urological disease and urological care providers face ma

104 d forms of CA, are less common but can cause urological disease including urinary retention and prost

105 Urological diseases and their varied forms of management

106 g, or prediction of therapeutic responses of urological diseases involving the kidney, prostate, and

107 on disease pathogenesis, many patients with urological diseases undergo high-tech, resource-intensiv

108 Regarding benign urological diseases, a burgeoning body of work exists on

109 intraoperative imaging in the management of urological diseases.

110 s interested in microbiome research in other urological diseases.

111 rine diagnostics are crucial for identifying urological disorders and systemic diseases.

112 ma in a large group of patients with various urological disorders could be used in the diagnosis of o

113 p in finding effective treatments for common urological disorders such as overactive bladder and inte

114 Among EPE-exposed subjects, urological disorders were associated with the highest ad

115 because many symptoms are shared with other urological disorders.

116 in the surgical management of six paediatric urological disorders.

117 iosis, developmental delay and pulmonary and urological dysfunctions.

118 Acute urinary retention (AUR) is a common urological emergency and affects a significant patient p

119 and upper gastrointestinal, lung, skin, and urological) for the period April 1, 2013, to March 31, 2

120 ificial sweeteners in bladder sensations and urological function.

121 ciprocal communication between the brain and urological, gastrointestinal, and immune systems.

122 uld be catheters tailored to cardiovascular, urological, gastrointestinal, and neurovascular applicat

123 ee groups (1:1:1; stratified by tumour site [urological, gynaecological, or gastrointestinal], and de

124 based diets are associated with benefits for urological health.

125 we recommend that only patients with a prior urological history should undergo this costly and often

126 VCUG studies to those patients with a prior urological history would have resulted in a significant

127 nly 56 of 517 patients evaluated had a prior urological history.

128 ast 10 years, we have seen major advances in urological imaging including developments in digital ima

129 een increasingly used across a wide range of urological indications, including robot-assisted radical

130 Management often involves endo-urological interventions and open surgery.

131 herapeutic gain, are well exemplified by the urological malignancies of renal, bladder, prostate, and

132 vestigating autologous cellular therapies in urological malignancies.

133 l cell carcinoma (RCC) is the most deadly of urological malignancies.

134 Renal cancer (RC) is the most lethal urological malignancy with 30% late diagnosis.

135 ear cell renal cell carcinoma is a prevalent urological malignancy, imposing substantial burdens on b

136 emission tomography scanning with regards to urological malignancy.

137 o illuminate the factors associated with the urological management of NLUTD among individuals with tr

138 highlighting recent advances with respect to urological minimally invasive surgery (MIS).

139 Urological obstructive complications (UOC) affect up to

140 are two outstanding unmet medical needs for urological oncologists.

141 Well-designed clinical trials in urological oncology help to guide treatment decisions an

142 olled, phase 2 trial was conducted across 41 urological oncology sites in 11 countries in Europe and

143 In current urological oncology, HIFU is used clinically in the trea

144 es) are well suited to advance innovation in urological oncology.

145 ymptoms or complications need referral for a urological opinion to determine the need for further inv

146 nts with lung (OR, 2.07; 95% CI, 1.12-3.65), urological (OR, 1.94; 95% CI,1.08-3.49), gynecological (

147 cluded adults who underwent 1 of 10 general, urological, or gynecological operations between January

148 ars who underwent elective general surgical, urological, or orthopedic procedures (N = 211,202).

149 ews the different approaches used by leading urological organizations to the development of prostate

150 of patients with prostate cancer by leading urological organizations.

151 General, gynecological, urological, orthopedic, and cardiac surgery.

152 included adult patients undergoing general, urological, orthopedic, and gynecological surgical proce

153 Three experienced academic urological pathologists (W.H., K.A.I., and R.H., hereina

154 International Society of Urological Pathologists biopsy grade group was 3 in 5 pa

155 opsies individually graded by 23 experienced urological pathologists from the International Society o

156 rostate biopsies and a worldwide shortage of urological pathologists puts a strain on pathology depar

157 des assigned by the AI system and the expert urological pathologists using Cohen's kappa.

158 by tumor cells were blindly evaluated by two urological pathologists, and outcome analyses were condu

159 pared to those generated by three specialist urological pathologists, with a Pearson correlation of 0

160 published based on a consensus conference of urological pathologists.

161 = 0.012; HR 2.264), International Society of Urological Pathology (ISUP) grade > 3 (p = 0.02; HR 1.96

162 nt was detection of International Society of Urological Pathology (ISUP) Grade >=2 cancer (clinically

163 International Society of Urological Pathology (ISUP) grade 2 or higher was consid

164 1007 uptake and the International Society of Urological Pathology (ISUP) grade and prostate specific

165 -risk PCa (>= cT3a, International Society of Urological Pathology (ISUP) grade group >= 3 or prostate

166 ants had lesions of International Society of Urological Pathology (ISUP) grade group (GG) 2 or higher

167 tate cancer with an International Society of Urological Pathology (ISUP) grade group of 2 or more, wh

168 disease, defined as International Society of Urological Pathology (ISUP) grade of 2 or greater on fol

169 Lesions with an International Society of Urological Pathology (ISUP) grade of 2 or higher (range,

170 ific antigen level, International Society of Urological Pathology (ISUP) grade, and clinical stage as

171 The International Society of Urological Pathology (ISUP) has recently adopted a progn

172 was higher when the International Society of Urological Pathology (ISUP) score was at least 4 versus

173 ally insignificant (International Society of Urological Pathology [ISUP] grade 1) prostate cancer; de

174 with sPC defined as International Society of Urological Pathology Gleason grade group greater than or

175 ficant PCa (csPCa) (International Society of Urological Pathology grade > 1) between January 2012 and

176 ly significant PCa: International Society of Urological Pathology grade >= 2).

177 ly significant PCa (International Society of Urological Pathology grade >=2) were calculated for bpMR

178 RY score and csPCa (International Society of Urological Pathology grade group >= 2) were evaluated.

179 ncer was defined as International Society of Urological Pathology Grade Group 2 or higher.

180 ecificity for CSPC (International Society of Urological Pathology grade group 2) were compared for (6

181 ed biopsy-confirmed International Society of Urological Pathology grade group 4-5 PAC, by four indepe

182 ate adenocarcinoma (International Society of Urological Pathology grade group = 1 in those <70 years

183 calculated, with an International Society of Urological Pathology grade group of at least 2 (csPCa) o

184 se in 71.4%, and an International Society of Urological Pathology grade group of at least 3 in 59.2%.

185 ostic tools such as International Society of Urological Pathology Grade Group, pretreatment serum PSA

186 sed of PSA density, International Society of Urological Pathology grade group, Prostate Imaging Repor

187 With increasing International Society of Urological Pathology grade group, the percentage of pati

188 PSA values and the International Society of Urological Pathology grade group.

189 serum of low-grade (International Society of Urological Pathology Grade Group/GG1), intermediate-grad

190 5% CI, 1.41-2.31]), International Society of Urological Pathology grade in surgery specimen (grade 5

191 The risk of significant urological pathology increases with the severity of pren

192 PSA doubling time, International Society of Urological Pathology score, and the number of foci.

193 e-specific antigen, International Society of Urological Pathology stage, MRI grade) predicted patholo

194 thologists from the International Society of Urological Pathology.

195 nificantly enhanced at later stages when the urological phenotype is severe, and the mutant bladders

196 g the potential application of proteomics in urological practice, and the future direction of proteom

197 trials cannot always be generalized to daily urological practice, it is important to complement them

198 Although well described in general urological practice, there is comparatively little resea

199 scribed adjuncts to many aspects of clinical urological practice.

200 y, and also as a potential paradigm shift in urological practice.

201 sical examination is an integral part of our urological practice.

202 logy that is shifting from the laboratory to urological practice.

203 Despite variation in common urological practices between spinal cord injury units an

204 Urolithiasis is a common urological problem, often requiring efficient workup, ac

205 nction was noted in 3 of 14 patients, but no urological problems occurred.

206 The samples associated with drug toxicity, urological problems, or recurrence of primary disease we

207 pen surgery for commonly performed pediatric urological procedures such as pyeloplasty, ureteral reim

208 iotic treatment only for patients undergoing urological procedures that lead to mucosal bleeding, cat

209 tial number of reports on performing complex urological procedures with robotic assistance in humans

210 o the armamentarium for performing different urological procedures.

211 rent surgeons performing 13 robotic-assisted urological procedures.

212 ergoing a variety of thoracic, abdominal and urological procedures.

213 tolerated and advantageous in reconstructive urological procedures.

214 Urological prostheses have been available and widely use

215 pain, injuries, metabolic, digestive, skin, urological, reproductive and sensory conditions.

216 e sites (Carcinoma of the Prostate Strategic Urological Research Endeavor, Center for Prostate Diseas

217 sthetic that is commonly used in preclinical urological research, has a profound, dose-dependent effe

218 Urological residents, fellows, and faculty attending sur

219 , and their true efficacy and utility in the urological setting has not been determined.

220 stems such as the gastrointestinal tract and urological structures.

221 Many urological studies rely on models of animals, such as ra

222 In this Viewpoint, authors from different urological subspecialties and at different career stages

223 also be perceived as a threat to the future urological surgeon.

224 theatre will directly affect the role of the urological surgeon.

225 ched in a siloed single-speciality way, with urological surgeons managing the localised stages of the

226 : This quality improvement study included 10 urological surgeons participating in a surgical collabor

227 The imaging evaluation of urological surgeries is often a radiological challenge,

228 Interest is growing within the urological surgery community for objective assessments o

229 2021 with data registered with the Michigan Urological Surgery Improvement Collaborative (MUSIC), a

230 his cohort study used data from the Michigan Urological Surgery Improvement Collaborative on men who

231 ng radical prostatectomy within the Michigan Urological Surgery Improvement Collaborative who agreed

232 hort study included 4582 men in the Michigan Urological Surgery Improvement Collaborative who underwe

233 Paediatric urological surgery is often required for managing congen

234 aroscopy and robotic-assisted reconstructive urological surgery on the lower urinary tract.

235 gynecology oncology, bariatric, general, and urological surgery were included.

236 , four gynaecological, two thoracic, and one urological surgery), involving 45 445 patients.

237 ciples and the sequelae of injury related to urological surgery, urologists can be more mindful of th

238 ports the use of autonomous robotic-assisted urological surgery.

239 a pivotal advancement in minimally invasive urological surgery.

240 ng the use of PROMs following reconstructive urological surgery.

241 te cancer models are an emerging adjunct for urological surgical planning and patient education, howe

242 Preoperative urological symptoms (odds ratio [OR] 3.2) and violation

243 ts suffering from IBS frequently suffer from urological symptoms characteristic of interstitial cysti

244 pread in the diagnostic evaluation of common urological symptoms, the planning of surgery and the tra

245 , is a commonly diagnosed and poorly treated urological syndrome.

246 ques have been used to detect cancers of the urological system (kidney, prostate and bladder) and non

247 at risk of chronic pain and infection in the urological system.

248 tive will discuss in detail the unsuccessful urological trials of CCBs and the promise of Cav1.2 agon

249 cer (BC) is one of the most lethal malignant urological tumors.

250 ll carcinoma (RCC) is one of the most lethal urological tumors.

251 omography scanning is capable of visualizing urological tumours and associated lymph nodes and distal